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Abstract
Bovine-heart NADH:ubiquinone oxidoreductase (EC 1.6.5.3; Complex I) is the first and most complicated enzyme in the mitochondrial
respiratory chain. Biochemistry textbooks and virtually all literature on this enzyme state that it contains one FMN and at least four iron–
sulfur clusters. We show here that this statement is incorrect as it is based on erroneous protein determinations. Quantitative amino acid
analysis of the bovine Complex I, to our knowledge the first reported thus far, shows that the routine protein-determination methods used for
the bovine Complex I overestimate its protein content by up to twofold. The FMN content of the preparations was determined to be at least
1.3–1.4 mol FMN/mol Complex I. The spin concentration of the electron paramagnetic resonance (EPR) signal ascribed to iron–sulfur
cluster N2 was determined and accounted for 1.3–1.6 clusters per molecule of Complex I. These results experimentally confirm the
hypothesis [FEBS Lett. 485 (2000) 1] that the bovine Complex I contains two FMN groups and two clusters N2. Also the protein content of
preparations of the soluble NAD+-reducing [NiFe]-hydrogenase (EC 1.12.1.2) from Ralstonia eutropha, which shows clear evolutionary
relationships with Complex I, scores too high by the colorimetric protein-determination methods. Determination of the FMN content and the
spin concentration of the EPR signal of the [2Fe–2S] cluster shows that this hydrogenase also contains two FMN roups. A third enzyme
(Ech), the membrane-bound [NiFe]-hydrogenase from Methanosarcina barkeri which shows an even stronger evolutionary relationship with
Complex I, behaves rather normal in protein determinations and contains no detectable acid-extractable FMN in purified preparations.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Bovine-heart NADH:ubiquinone oxidoreductase (EC
1.6.5.3; Complex I) is located in the inner membrane of
mitochondria. It catalyzes the transfer of electrons from
NADH to ubiquinone and couples this to the extrusion of
protons from the mitochondrial matrix (for review, see e.g.
Refs. [1,2]). The resulting proton-motive force drives the
synthesis of ATP from ADP and inorganic phosphate. Mal-
functioning of Complex I can give rise to severe diseases in
man, for example, Parkinson’s disease and several mitochon-
drial encephalomyopathies [3,4]. Moreover, one of its sub-
units is probably involved in apoptotic cell death [5].
The bovine Complex I consists of 43 different polypep-
tides [1,5] with a total molecular mass of over 900 kDa. A
crystal structure is not available. Chemical analyses of
purified preparations for FMN and Fe by two pioneering
groups in this field [6–11] showed the presence of 16–18
non-haem Fe atoms per FMN. As such Complex I prepa-
rations are often contaminated with some Complex II
(succinate:ubiquinone oxidoreductase) and Complex III
(ubiquinol:ferricytochrome c oxidoreductase), which also
contain Fe–S clusters but no FMN, these numbers are
upper values. Electron paramagnetic resonance (EPR) stud-
ies of the NADH-reduced enzyme showed the presence of
four different EPR signals. One signal could be ascribed to
a [2Fe–2S] cluster, whereas the other three signals were
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demonstrated to be due to [4Fe–4S] clusters. EPR spectra
of the purified preparations were identical to those of the
enzyme as present in submitochondrial particles (for over-
view, see Ref. [12]). There is a general agreement in the
field that the total number of spins represented by these
signals is 3.5–4 per FMN [12–14]. Therefore, it has been
assumed early on [12] that the bovine Complex I contains
one FMN, one [2Fe–2S] cluster (called N1b), and three
[4Fe–4S] clusters (N2, N3 and N4). An additional EPR
signal, due to a [2Fe–2S] cluster, could be detected only at
very low redox potentials [15], but in the membrane-bound
enzyme or the Hatefi-type Complex I, this cluster (N1a) is
not reducible by NADH. Magnetic circular dichroism
(MCD) studies eliminated the possibility of paramagnetic,
EPR-silent Fe–S clusters [9]. So, these EPR and MCD data
predicted the presence of two 2Fe clusters and three 4Fe
clusters, resulting in 16 Fe atoms per FMN, in good agree-
ment with the earlier data from chemical analyses. This is
why Biochemistry textbooks as well as most research
papers on Complex I, including those on Complex I from
bacterial origin, state that this enzyme contains one FMN
and four to five Fe–S clusters.
Flavine determinations of an enzyme with a molecular
mass of over 900 kDa [5], containing one FMN molecule,
should result in no more than 1.1 nmol FMN/mg protein. The
classical preparations of bovine Complex I were already
reported to contain considerably more flavine: 1.2–1.5 nmol
FMN/mg protein [6–8,10,11]. A more recent purification
procedure [16] resulted in preparations with 1.5–1.6 nmol
FMN/mg protein, but this preparation, termed 1a, contained
at most 29 of the 43 subunits of the parent Complex I.
As these values (1.2–1.5 nmol FMN/mg protein for the
full complex) considerably exceed the value (1.1 nmol/mg)
for an enzyme of 900 kDa with one FMN group, but are
lower than the value (2.2 nmol/mg) for such an enzyme with
two FMN groups, we decided to closely inspect the reli-
ability of the routine protein-determination methods for
obtaining the concentration of Complex I. We found that
these methods grossly overestimate the protein content of
the bovine enzyme. We show that the bovine Complex I
contains clearly more than one FMN group and up to 1.6
clusters N2. A number of puzzling literature data on Com-
plex I and some consequences of this finding are discussed.
The evolutionary related enzyme, the soluble NAD+-reduc-
ing [NiFe]-hydrogenase (EC 1.12.1.2) from Ralstonia eutro-
pha also shows too high proteins contents by the routine
protein-determination methods. This enzyme likewise con-
tains two FMN groups.
2. Materials and methods
2.1. Protein samples
Two bovine mitochondrial Complex I samples were
used. One [17] was a kind gift from Dr. L.A. Sazanov
(Cambridge, UK) while the other sample was from a
previous study [16] and had been stored in liquid nitro-
gen. Soluble, NAD+-reducing hydrogenase (SH) from R.
eutropha was purified as described [18]; the cells were
kindly provided by the group of Prof. B. Friedrich
(Berlin, Germany). The samples of the membrane-bound
[NiFe]-hydrogenase (Ech) from Methanosarcina barkeri
[19] were gifts from Dr. R. Hedderich (Marburg, Ger-
many).
2.2. Protein determinations
Four different routine protein-determination methods
were used: the biuret method [20,21], the Bradford method
[22], the Lowry method [23] and the bicinchoninic acid
(BCA) method [24] (Pierce). Ovalbumin or bovine serum
albumin (BSA) were used as standards; their concentra-
tions were obtained from the optical absorption at 279 nm
(BSA; A279 nm = 6.67 for a 1% solution [25]) or 280 nm
(ovalbumin; A280 nm = 7.37 for a 1% solution, based on an
extinction coefficient of 3.15 M 1 cm 1 [25] and a
molecular mass of 42755 Da). Quantitative amino acid
analysis was performed as described [26] (EuroSequence
bv, Groningen, The Netherlands). For this method, all
protein solutions were extensively dialyzed against 5
mM potassium phosphate buffer (pH 7.0). Samples were
recovered from the dialysis bag and their volumes and
protein concentrations (Bradford) were measured. This
accounted for dilution and possible loss of protein. Sub-
sequently, known amounts were freeze-dried for the anal-
ysis. As the proteins were hydrolyzed in 50% acetic acid,
Asn and Gln were deamidated into Asp and Glu, respec-
tively. As this does not influence the mass, no corrections
were made for this. Trp and Cys could not be determined
after this treatment, but here a correction was made on the
basis of the sequences of 41 subunits of the bovine
Complex I (5.3%), or the sequences of R. eutropha SH
(5.6%), M. barkeri Ech (4.4%), ovalbumin (2.7%) and
BSA (6.0%).
2.3. EPR spectroscopy
EPR spectra at X-band (9 GHz) were obtained with a
Bruker ECS 106 EPR spectrometer at a field-modulation
frequency of 100 kHz. Cooling was performed by an
Oxford Instruments ESR 900 cryostat with a ITC4
temperature controller. The sample-temperature indication
from this instrument was correct from 4.2 to 100 K
within F 2% as ascertained from the Curie dependence
of a copper standard (10 mM CuSO45H2O, 2 M
NaClO4, 10 mM HCl). The magnetic field was calibrated
with an AEG Magnetic Field Meter. The X-band fre-
quency was measured with a HP 5350B microwave
frequency counter. The microwave power incident to
the cavity was measured with a HP 432 B power meter
(260 mW at 0 dB). Manipulations and simulations of
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EPR spectra were carried out with homemade software
[12]. Quantification of EPR signals from the membranes
was performed by double integration of well-fitting
simulations [27,28]. Spectra from the copper standard
were directly double integrated and used as a reference
[29].
2.4. Other methods
Acid-extractable flavine was determined fluorometri-
cally [30], using FMN (synthetic, from Sigma) as a
standard, in a Shimadzu RF-5001PC spectrofluorometer.
The concentration of the standard (in a buffer solution of
pH 6.9) was calculated from the difference in absorption
at 450 nm before and after addition of excess dithionite
using an extinction coefficient of 11.2 mM 1 cm 1
[31].
3. Results
3.1. Protein determinations
We have determined the protein content of bovine
Complex I preparations by quantitative amino acid anal-
ysis and by four conventional methods (Table 1). The
routine methods overestimate the protein content of this
enzyme by between 1.3 and 2.1 times. The albumin
samples showed that our overall method was highly
reliable. We have also included into this study two
enzymes that have clear evolutionary links to Complex
I, namely the soluble NAD+-reducing [NiFe]-hydrogenase
(SH) from R. eutropha [13,32–35] and the membrane-
bound [NiFe]-hydrogenase (Ech) from M. barkeri [19,36].
The routine protein-determination methods overestimated
the protein content of the R. eutropha SH by between 1.4
and 1.9 times. The Bradford protein-determination
method, used for all enzymes in Table 1, overestimated
the protein content of bovine Complex I by 1.76 times,
that of the R. eutropha SH by 1.53 times, but slightly
underestimated (0.85 times) the protein content of the M.
barkeri Ech.
We have also compared the experimentally determined
amino acid composition of the samples with the theo-
retically predicted ones. This is depicted in Fig. 1a.
Deviations, calculated as explained in the legend to
Fig. 1, were plotted for each individual amino acid
(except for Trp and Cys). The residues Asn and Asp,
as well as Gln and Glu were taken together, due to the
conversion of the amide form into the acid form during
the amino acid analysis procedure. It can be seen that
the deviations for the several enzyme preparations are of
the same magnitude as the deviations found for the pure
albumin samples. When the theoretical values of the
enzyme preparations were taken as basis for a compar-
ison with the experimentally determined values for the
albumins (Fig. 1b), it can be seen that, as expected, the
deviations are much (about five times) larger. Hence, the
method clearly detects that the amino acid composition
of the albumins is quite different from that of each of
the enzymes. The data thus show that the amino acid
composition of the samples agreed very well with that
calculated from the amino acid sequences of the sub-
units.
Table 1
Protein determinations of bovine Complex I and two related enzymes
Preparation Method
Bradford (mg/ml) Lowry (mg/ml) Biuret (mg/ml) BCA (mg/ml) AAa (mg/ml) Ratiob (Br/AA) Rangec (Col/AA)
Complex Id 23.4 27.4 26.4 24.7 13.3 1.76 1.76–2.06
Complex I (MQ)e 20.5 24.1 15.3 17.2 11.6 1.77 1.32–2.08
R.e. SH (a)f 15.8 20.7 16.2 16.1 10.7 1.48 1.48–1.93
R.e. SH (b)f 22.2 26.3 19.5 21.9 14.1 1.57 1.38–1.87
Echg 4.5 – – – 5.2 0.87 –
Echg 3.4 – – – 4.6 0.74 –
Echg 3.6 – – – 3.8 0.95 –
Ovalbuminh (2.0 mg/ml; from A280 nm) 2.0 (1.00)
i
BSAh (5.0 mg/ml; from A279 nm) 4.9 (1.02)
i
BSAh (4.5 mg/ml; from A279 nm) 4.6 (0.98)
i
BSAh (4.6 mg/ml; from A279 nm) 4.3 (1.07)
i
a Amino acid analysis.
b Ratio of the protein content determined by the Bradford method (Br) and that determined with amino acid analysis (AA).
c Ratio of the protein content determined by the colorimetric methods (Col) and that determined with amino acid analysis (AA).
d Bovine mitochondrial Complex I (gift from Dr. L.A. Sazanov).
e A sample used in a previous study [16], prepared according to Ref. [68].
f Two different preparations of the soluble, NAD+-reducing hydrogenase from R. eutropha.
g Three different preparations of the membrane-bound [NiFe]-hydrogenase (Ech) from M. barkeri (gifts from Dr. R. Hedderich).
h Control samples to validate the overall method.
i Ratio of the protein content determined from the absorbance at 279 or 280 nm and that determined by amino acid analysis.
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3.2. FMN content
Our findings have important implications for the FMN
content of both Complex I and the R. eutropha SH.
When corrected for the systematic error in the protein
determination, the FMN contents (1.2–1.5 nmol FMN/mg
protein) reported in literature for the most purified
preparations of bovine Complex I should be raised to
values around 2.2 nmol/mg, as expected for pure Com-
plex I with two FMN molecules. The R. eutropha SH
was reported to contain 1.1–1.4 mol FMN/mol enzyme,
using the Lowry and biuret methods to determine the
protein content [37]. Our results (Table 1) show that
these values should be multiplied by about 1.6 times and
then become 1.8–2.2 mol FMN/mol enzyme. Hence, we
predict that also the R. eutropha SH contains two FMN
groups.
To experimentally verify this for the preparation used
in Table 1, we have determined acid-extractable FMN in
these preparations. The results are summarized in Table
2. The two inspected samples of the complete Complex I
contained 1.5–1.6 nmol FMN/mg protein (AA method).
Assuming a molecular mass of 900 kDa or more, this
means that these preparations contained at least 1.3–1.4
mol FMN/mol Complex I. The two samples of the R.
eutropha SH contained 10.6 and 8.8 nmol FMN/mg
protein (AA method). With a mass of 171 kDa for this
four-subunit enzyme, this results in 1.8 and 1.5 mol
FMN/mol enzyme, respectively. We could not detect
any acid-extractable FMN in the M. barkeri Ech.
We have also compared the FMN content with an
internal standard (Table 2). The area of the left-half of
the gz peak (at g = 2.05) of the EPR signal at 17 K from
iron–sulfur cluster N2 is a reliable measure for the
concentration of this cluster in NADH-reduced Complex
I [12,27]. When applying this method to the preparations
used in Table 2, we found 1.3–1.6 mol spins/mol
Complex I. This means that the FMN/N2 ratio was
1.05 for the Sazanov preparation [17] and 0.86 for
Finel’s MQ preparation [16]. These ratios are in full
agreement with values found by other workers. The
present data demonstrate, however, that the number of
spins detected in the EPR signal ascribed to iron–sulfur
Fig. 1. Comparison of the experimental amino acid composition of the
samples with the theoretical composition. (a) For each amino acid, the
theoretical number of residues per mol was derived from the amino acid
sequences; this was called nt. Likewise, the number of experimentally
determined residues per mol was called ne. These values were then
expressed as percentage of the total number of amino acids N, as p=(nt/N)
and q=(ne/N). Subsequently, the value r ={( q p)/q}(100%) was plotted in
the figure for each individual amino acid. Asn and Gln residues were
deamidated into Asp and Gly, respectively, during the experimental
procedure; therefore, only values for Asx and Glx are given. Trp and Cys
residues could not be determined. The values for Complex I, the SH from R.
eutropha, Ech and BSA are averages from the different analyses shown in
Table 1. (b) The experimental values (r) of BSA (solid lines) and ovalbumin
(dashed lines) were compared with the theoretical values of Complex I, R.
eutropha SH or Ech. In this case, the experimental values q were from BSA
or ovalbumin, whereas the theoretical values p were from the reference
enzymes mentioned. Note that the y-scaling in B is approximately five
times reduced as compared with A.
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cluster N2 for the preparations investigated in this study
(1.3–1.6 mol/mol Complex I; Table 2) warrants the
conclusion that there is clearly more than one cluster
N2 in these preparations.
With the SH, the EPR signal at 45 K of the NADH-
reducible [2Fe–2S] cluster is a reliable measure of the
enzyme concentration, provided that a good-fitting simu-
lation is used for the double integration procedure [27].
In this case, 1.0 mol spins/mol SH was found in both
preparations and hence the value of the FMN/[2Fe–2S]
ratio was 1.82 and 1.51 for the preparations a and b,
respectively.
4. Discussion
4.1. The number of prosthetic groups in bovine Complex I
To our knowledge, this report is the first study that
combines quantitative amino acid analysis of bovine Com-
plex I with quantitative determinations of the FMN content
and the spin concentration of the EPR signal ascribed to
cluster N2. The data clearly show that the bovine Complex
I contains more than one FMN group: (i) at least 1.4 FMN
for the intact preparations used in this study; (ii) close to
two for the best preparations reported in the literature,
when corrected for the error in the protein determination.
We therefore conclude that bovine Complex I contains two
FMN groups.
Our data likewise demonstrate that 1.3–1.6 S = 1/2
systems per Complex I contribute to the EPR signal
ascribed to cluster N2. As Complex I preparations are
never ‘100% pure’, these values are lower limits. We
conclude from this that bovine Complex I contains two
clusters N2 with highly similar EPR signals. As the spin
concentrations determined from the EPR signals ascribed
to the clusters N3 and N4 are the same as the spin
concentration of the signal ascribed to cluster N2, it
follows that also the individual signals ascribed to N3
and N4 each receive contributions from two separate
S = 1/2 systems.
4.2. There are two FMN groups in the SH
Table 2 shows that the amount of spins represented in the
EPR signal of the [2Fe–2S] signal in the NADH-reduced
SH is 1.0 mol/mol enzyme in both preparations. This shows
that both the method of determination of the spin concen-
tration as well as the method of protein determination (AA
method) are reliable. The amount of FMN was 1.5–1.8 mol/
mol enzyme. We therefore conclude that the SH contains
two FMN groups. We recently found that under certain
conditions, one of the FMN groups in the Ralstonia enzyme
can be specifically released, whereby the physiological
activity of the enzyme, the reduction of NAD+ by H2, was
abolished. One FMN group remained firmly bound to the
enzyme and the NADH-dehydrogenase activity was not
perturbed (Van der Linden, E., Faber, B., Bleijlevens, B.,
Burgdorf, T., Bernard, B., Friedrich, B. and Albracht, S.P.J.,
manuscript in preparation).
4.3. Proposed binding site for the second FMN
One of the two FMN groups is bound to the 51-kDa
subunit of Complex I, which contains an FMN-binding
motif [38]. The binding site of the other FMN is discussed
hereafter. On the basis of extensive comparisons of the
amino acid sequences of [NiFe]-hydrogenases and Complex
I [36], it has been found that the basic elements of the
typical flavodoxin fold observed in the X-ray structures of
[NiFe]-hydrogenases are also present in the evolutionary
related PSST subunits of all Complex I enzymes known.
Hence, a flavodoxin fold was proposed to be present in the
PSST subunit. In looking for a binding site for the extra
FMN group uncovered in the present report, the PSST
subunit in the bovine Complex I is the obvious choice.
For the soluble [NiFe]-hydrogenase from R. eutropha, the
HoxF subunit contains an FMN-binding motif and binds the
FMN involved in the NADH-dehydrogenase reaction. We
propose that the HoxY subunit binds the second FMN.
A schematic representation of the prosthetic group in
bovine Complex I, based on these new experimental results,
is given in Fig. 2.
Table 2
FMN content of bovine Complex I and the NAD+-reducing [NiFe]-hydrogenase (SH) from R. eutropha
Preparation FMN nmol/mga
(mol/mol)
N2 nmol/mga,b
(mol/mol)
FMN per N2c [2Fe–2S] nmol/mga,d
(mol/mol)
FMN per [2Fe–2S]
clustere
Complex I 1.48 (1.33) 1.42 (1.28) 1.05 – –
Complex I (MQ) 1.55 (1.40) 1.80 (1.62) 0.86 – –
R.e. SH (a) 10.6 (1.82) – – 5.86 (1.0) 1.81
R.e. SH (b) 8.8 (1.51) – – 5.83 (1.0) 1.51
The FMN content was also compared with an internal standard, that is, the spin concentration of the EPR signal ascribed to cluster N2 (Complex I) or the
[2Fe–2S] cluster (SH).
a Protein determined by amino acid analysis.
b From the spin concentration of the EPR signal at 17 K ascribed to cluster N2 in the NADH-reduced preparations.
c Ratio of the concentrations of FMN and the Fe–S cluster N2.
d From the spin concentration of the EPR signal of the [2Fe–2S] cluster at 45 K as determined in NADH-reduced enzyme.
e Ratio of the concentrations of FMN and the [2Fe–2S] cluster.
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4.4. Puzzling observations on Complex I can now be
explained
At this point, it is useful to recall a number of exper-
imental findings in the long literature on the bovine Com-
plex I, that can now be more easily understood.
(A) About three decades ago, Hatefi [39] noted an optical
bleaching of purified Complex I (measured at 460–510 or
475–510 nm) when NADH was added. Curiously, in the
presence of the inhibitor rotenone, only half of this bleach-
ing was observed. When NADPH was used, then also only
about 50% of the bleaching induced with NADH was
observed [40]. Subsequent addition of NADH immediately
resulted in the full bleaching. When NAD+ was added
instead, a complete bleaching was only obtained in a slow
reaction; this reaction, in fact a transhydrogenase activity of
the purified Complex I, could be inhibited by palmitoyl-
CoA. It was later established that rotenone did not inhibit
the reduction of any of the EPR-detectable Fe–S clusters in
the bovine complex [41]. Hence, it can be concluded that
the redox component responsible for about 50% of the total
bleaching of bovine Complex I is apparently not one of the
EPR-detectable Fe–S clusters or the flavine (FMN-b)
required for the oxidation of NADH. The presence of a
second flavine group (FMN-a), which can specifically react
with NADPH, solves this long-standing puzzle. Incidentally,
these classical experiments, in combination with the present
knowledge on Complex I, suggest that (i) the FMN-a group
may be the site where the transhydrogenase activity of
Complex I is catalyzed (reduction by NADPH, oxidation
by NAD+) and (ii) that rotenone interferes with electron
transfer from the Fe–S clusters to the FMN-a group. In this
respect, it is worthwhile to recall that the PSST subunit
specifically binds a photoaffinity derivative of pyridaben
[42], a potent inhibitor of Complex I. This binding is
counteracted by other inhibitors like rotenone, piericidin
A, bullatacin and rolliniastatin I [42].
(B) Quantification by our laboratory of the EPR signals
ascribed to the Fe–S clusters N1b and N2 clearly showed
that the relative intensities of these signals (a direct measure
of their relative concentrations) in the purified enzyme, as
well as in the enzyme in submitochondrial particles, differ
by a factor of 2 [27,43–45]. It was demonstrated a decade
ago [45] that the direct double integration of the exper-
imental EPR signal of cluster N1b at around 50 K, as
commonly used in the Complex I field up to that time,
results in a considerable overestimation of the concentration
of this cluster, due to the broad underlying signals of the
relaxation-broadened EPR spectra of the [4Fe–4S] clusters.
The correct way to determine the spin concentration for the
signal due to cluster N1b is to use a good-fitting computer-
simulated line shape for the double integration [27,45]. It
then turned out that the intensity of this signal was half that
of the signal ascribed to cluster N2 (and half of the
intensities of the signals ascribed to the cluster N3 and
cluster N4). The number of spins represented by the signal
ascribed to cluster N2 was close to one per FMN, as also
determined for the Complex I preparations used in the
present study. This prompted this laboratory already more
than two decades ago [27,43] to propose: (i) that each of the
EPR signals ascribed to the clusters N2, N3 and N4 must
receive contributions from two different clusters with very
similar EPR line shapes (N2a, N2b, N3a, N3b, N4a, N4b);
(ii) that the minimal enzymatic unit of the bovine Complex I
must at least contain one cluster N1b, two FMN groups and
one of the six clusters mentioned above.
(C) Kinetic studies (steady state and pre-steady state)
with aerobic submitochondrial particles at pH 7.5 or higher
showed that NADPH can rapidly (within 50 ms) evoke
maximally 50% of the EPR signals ascribed to the clusters
N2, N3 and N4. This reduction was interpreted as a specific
reduction of the clusters N2a, N3a and N4a. The reduction
persisted for minutes without noticeable oxygen consump-
tion [28,46,47]. Cluster N1b was not reduced. As electrons
Fig. 2. Schematic representation of the five subunits of bovine Complex I (the 24-, 51- and 75-kDa, PSST and TYKY subunits) containing the prosthetic
groups, plus the 49-kDa subunit. The clusters N1a and N1b are [2Fe–2S] clusters; the clusters N2a, N2b, N3a, N3b, N4a and N4b are [4Fe–4S] clusters.
NADPH can reduce FMN-a and the clusters N2a, N3a and N4a, but the electrons cannot reach ubiquinone (Q) [28]. NADH can reduce all prosthetic groups
except cluster N1a. ADP-ribose is an inhibitor of NADH oxidation, but has no effect on the energy-driven reduction of NAD+ [52].
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did not leave Complex I, the apparent point of entrance for
electrons from NADPH was assumed to be different from
the point of entrance for electrons from NADH. The clusters
N1b, N2a, N2b, N3a, N3b, N4a and N4b are all reduced
within 6 ms when NADH is used [12]. For each reaction,
the reaction with NADPH and the reaction with NADH, a
flavine was assumed to be a prerequisite. These data can
now be more easily understood. They showed, however,
that there is apparently no redox equilibrium between the
clusters when NADPH is used as the electron donor. This
still remains a mystery.
(D) Piericidin A is a well-known potent inhibitor of the
bovine Complex I. It was shown that the oxidation of
NADH by submitochondrial particles can be completely
blocked when only one piericidin molecule per two clus-
ters N2 (N2a +N2b) is bound to the enzyme, provided that
the particles were preincubated with the inhibitor in the
presence of NADPH [48]. Again, this pointed to a minimal
enzymatic unit with two clusters N2 and two FMN groups.
With a preincubation in the presence of NADH, however,
two piericidin molecules per two clusters N2 were required
[48]. The latter result is in agreement with findings of
other groups who, by using labelled inhibitors, have shown
that the bovine complex in submitochondrial particles has
two binding sites for rotenone, piericidin A and 1-methyl-
4-phenylpyridinium (MPP+) [49–51] and that (in experi-
ments without a preincubation with NADPH) both inhib-
itor sites must be occupied for the complete inhibition of
NADH oxidation. Initially, our laboratory explained the
findings under B, C and D by proposing a dimeric
structure of Complex I [28]. The dimeric model could be
replaced by a monomeric one [13] once information on the
amino acid sequences of the subunits from the bovine
enzyme became available from the group of Walker (see
below) [1,2,38].
(E) From the amino acid sequences of the subunits of
bovine Complex I, the binding sites for two 2Fe clusters, six
4Fe clusters and one FMN were predicted [38]. Assuming
that all Fe–S clusters but one, cluster N1a, would be NADH
reducible, this would lead to seven spins and a total of 28 Fe
atoms per FMN. Both of these numbers are nearly twofold
higher than those (3.4–4 spins and 16–18 Fe atoms per
FMN) determined by the EPR-spectroscopical and chemical
analyses mentioned in the introduction. The presence of a
second FMN, however, reduces these numbers to 3.5 spins
and 14 Fe atoms per FMN, in much better agreement with
the experimental data.
(F) From studies on coupled submitochondrial particles
with the inhibitor ADP-ribose [52], it was concluded that the
site for the reduction of NAD+, in the energy-induced
reversal of electron transfer in Complex I, is not the same
as that for NADH oxidation. The latter reaction is inhibited
by ADP-ribose, whereas the former reaction is not. It is
reasonable to assume that a flavine is required for each of
these reactions. The results can be easily understood in a
Complex I with two FMN groups with a different function.
4.5. Possible reason for the overestimation of the protein
content of Complex I
The reason for the overestimation of the protein content
by the routine methods is not quite clear. Lowry et al. [23]
already noticed that, when using pure proteins, their
method and the biuret method can result in protein
contents deviating considerably from true values. This
also holds for the Bradford assay [53]. The amino acid
sequences of the six subunits from the M. barkeri Ech are
closely similar to those of six of the subunits from
Complex I [36], but these subunits are apparently not
the cause for the overestimation of the protein content.
Two of the four subunits of the R. eutropha SH have
homologues in both Ech and Complex I. The other two,
HoxF and HoxU, form the NADH-dehydrogenase module
in this enzyme and are related to the NADH-dehydrogen-
ase part of Complex I [33]. The N-terminal sections of the
HoxU subunit in SH and of the 75-kDa subunit in
Complex I are similar to each other and to the N-terminal
part of the sequence from a number of [Fe]-hydrogenases
[13]. These sections contain common motifs for the bind-
ing of one [2Fe–2S] cluster and two [4Fe–4S] clusters.
The X-ray structure of the [Fe]-hydrogenase from Clostri-
dium pasteurianum shows that one of these 4Fe clusters
has a His residue as a ligand [54]. This His residue is
conserved in the sequence of the 75-kDa subunit of
Complex I, but not in that of the HoxU subunit of the
SH [13]. Incidentally, the routine protein determination
methods used for the [Fe]-hydrogenase from C. pasteur-
ianum also resulted in a large overestimation of the
protein content [55]. This points to the 75-kDa subunit
in Complex I and the HoxU subunit in SH as possible
contributors to this deviation.
5. Conclusions and implications
The results in this paper require a reinterpretation of a
number of observations in the recent literature on Complex
I. Three examples are discussed.
5.1. Bovine Complex I does not contain reducible, EPR-
silent Fe–S clusters
Rasmussen et al. [56] have proposed the presence of
EPR-undetectable, reducible Fe–S clusters in non-bovine
Complex I. From experiments with Complex I purified from
Neurospora crassa and Escherichia coli, it was concluded
that the TYKY subunit contains two [4Fe–4S] clusters
(termed N6a and N6b), both with a pH-independent mid-
point potential of  270 mV. The reduction of these clusters
could be detected with UV/Vis spectroscopy but caused no
detectable contribution to the EPR spectrum. The experi-
ments of Kowal et al. [9] and the results from the present
study exclude such a possibility for the bovine Complex I.
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5.2. In bovine Complex I, cluster N2 is not located in the
PSST subunit
Another example is the location of ‘the cluster N2’. On
the basis of studies on Complex I from Yarrowia lipolytica
[57] and N. crassa [58], where point mutations were
generated in analogues of the PSST and 49 kDa subunits,
it was concluded that the PSST subunit would be the
location of ‘cluster N2’. Because we show here that in the
bovine enzyme the EPR signal ascribed to cluster N2
receives contributions from two S = 1/2 systems (clusters
N2a and N2b) and because the PSST subunit contains only
one possible motif for the binding of a 4Fe cluster, this
proposal cannot hold for the bovine enzyme.
5.3. The clusters N2 in Complex I are located in the TYKY
subunit
The TYKY subunit has two classical amino-acid sequence
motifs (four-Cys motifs) for the binding of a 4Fe cluster [59]
and it was proposed that this subunit might hold cluster N2.
Our group has advocated the presence in this subunit of two
EPR-detectable clusters N2 [13,36]. It was assumed [13,36]
that these clusters have virtually identical EPR spectra in the
bovine enzyme. The paramagnetic clusters show a clear
exchange coupling under energized conditions in coupled
submitochondrial particles [60,61]. Under non-energized
conditions, as well as in isolated Complex I, no such
magnetic interaction has been observed, however.
The first experimental evidence for the presence of
[4Fe–4S] clusters in the TYKY subunit came from studies
on an overexpressed, truncated form of the Nqo9 (TYKY)
subunit from Paracoccus denitrificans, reconstituted with
iron and sulfide [62]. The g values of one of the two signals
in the EPR spectrum ( gxyz = 1.92, 1.92, 2.05) were similar to
those found in the membrane-bound complex [63,64]. The
midpoint potentials of the clusters ( < 600 mV) were,
however, very much lower than that of the N2 EPR signal
in the membrane-bound complex [62].
Quite recently, an extensive study focused at the effect of
point mutations in the NuoI (TYKY) subunit from Complex
I in Rhodobacter capsulatus has been completed (Ref. [65],
accompanying paper). Mutants in the NuoI (TYKY) subunit
were constructed in which five out of the eight conserved
Cys residues in NuoI were replaced by other residues. EPR
analysis of membrane preparations showed a specific, 50%
decrease of the signal attributed to cluster N2, when a
particular Cys residue in one or the other ‘four-Cys’ motif
was replaced by a Ser residue. The EPR signals of the other
clusters, as well as the activity of the complex in the isolated
membranes and its function in the growing cells, were
hardly perturbed. Replacement of the Cys residue by an
Arg residue abolished the biosynthesis of intact Complex I
in the membranes. This study provides the first direct
demonstration that point mutations in the TYKY subunit
specifically alter the properties of half of the EPR signal
ascribed to cluster N2. It shows that in this bacterium, the
clusters N2 are in the NuoI (TYKY) subunit and that an
intact Complex I cannot be formed if one of the [4Fe–4S]
clusters in the TYKY subunit is missing. This raises ques-
tions about the interpretation of the effects of mutations
leading to the partial loss or the complete absence of the
EPR signal of cluster N2 in purified, apparently completely
intact preparations of Complex I from Y. lipolytica [57] and
N. crassa [58]. This will be further discussed in the
accompanying paper [65].
In summary, the information presented here and in the
accompanying paper provide strong experimental evidence
that all the Fe–S clusters predicted by the amino-acid
sequence information [38] are EPR detectable when reduced
and that Complex I contains two FMN molecules. Reduc-
tion of the second FMN group (proposed to be in the PSST
subunit) might (partly) explain the UV/Vis-detected reduc-
tion of EPR-undetected redox groups in Complex I from
bovine heart [39,40], N. crassa and E. coli [56,66,67]. In
view of the high similarities of the amino acid sequences of
the subunits of Complex I from many different sources, with
their conserved motifs for the binding of Fe–S clusters and
FMN, and the proposed flavodoxin fold in the PSST
subunits, we feel that a reinvestigation of the FMN and
protein contents for the non-bovine enzymes is called for.
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